Mycoplasma Pneumoniae IgM WWHS FIA Rapid Quantitative Test Kit IVD

Product Description

Mycoplasma pneumoniae is among the smallest of free-living organisms. In humans, it is usually found

in the throat and lungs and is susceptible to antimicrobial agents that inhibit protein synthesis.

The spread of Mycoplasma infections depends on close and prolonged contact between people, as it is transmitted

by means of droplet nuclei from the respiratory tract.

Mycoplasma infection may be asymptomatic or may produce upper respiratory tract disease or atypical
pneumonia. The pneumonia is difficult to differentiate from viral diseases by clinical means alone.
Laboratory tests such as isolation, Complement Fixation serology, and ELISA serology are helpful as

an aid in the diagnosis

Characteristics

1. Accurate: Double antibody sandwich method, high sensitivity.
2. Rapid: Get results in 10 minutes.
3. Convenient: No need professional training, test could be performed at any time, any place.

Interpretation of Test Results

1. The kit can be used for auxiliary test only. If test result is abnormal, retest timely and judge combined with clinical symptoms.
2. For samples whose cTnI concentration is lower than 0.1ng/mL and higher than 40ng/mL, test result is “＜0.1ng/mL” and “＞40ng/mL” respectively.

As A Fast-Growing Biotechnology Company, WWHS Biotech.Inc(exclusive marketed by Dawin) Dedicate To The Development Of World-Class Bio-Detection Technologies That Meet The Ever-Increasing Demands On Clinical Diagnostics. We Focus On Developing Cost-Effective And Precise Rapid Diagnostic Products Based On Our Unique Near Infrared (NIR) Fluorescence Platform Technologies (PGOLD™ And IR-LF™) With Major Interests In Cardiology, Infectious Diseases, Oncology, Metabolic Diseases And Women And Children’s Health...